OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Olema Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$7.11+0.53 (+8.05%)
Close on Oct 19, 2026
- Market cap
- $742.67M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.25 (−24.04%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $742.67M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.72
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$204.57M
- EPS, diluted
- -$2.12
- Book value per share
- $4.12
- Diluted shares
- 104M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$221.13M
Net income
-$204.57M
EPS, diluted
-$2.12
Free cash flow
–
Reported periodTrailing twelve months